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Errors in the stage of prescribing make approximately 16 % of all medication errors. 
There is a need to identify the frequency of this, and also to assess the impact of 
contributions by pharmacists to the patient’s care. 
Aim and objectives: 
To characterise the nature and frequency of medicines errors in patients during the 
process of admission to hospital, and also to evaluate the new medicines 
reconciliation service at Ayr Hospital. 
Methods: 
A prospective audit survey was carried out at an acute medical receiving ward at Ayr 
Hospital. Patients’ records at admission were used to compare the drugs first 
prescribed by the doctor, with the list made by pharmacist. Patients seen by a 
pharmacist in the study period were asked to take part in the study. Information about 
the new MR service was obtained by looking into the MR-forms for each patient, and 
this was used as a basis for evaluating the service. 
Results: 
In the study period of 5 weeks there were recorded 255 contributions by pharmacist, 
distributed on 105 patients in total.  The median number of discrepancies found per 
patient was 2.4 and no discrepancies were found in 25/105 (23.8 %) of the cases.
Some 67.5 per cent of all the interventions were assessed to be significant and result 
in an improvement in the standard of care, while 6.7 per cent were assessed to be 
very significant and prevent a major organ failure or adverse reaction of similar 
importance.
Conclusion:
Pharmacists have an important role in improving the quality of patient care and 
contributions made by pharmacists are both important and necessary. 
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Medicines management is defined as “a system of processes and behaviours that 
determines how medicines are used by patients and by the NHS. Effective medicines 
management  services  will  have  the  patient  as  the  primary  focus,  thus  delivering 
better targeted care and better informed individuals”. 1
Medicines management in hospitals encompasses the entire way that medicines are 
selected, procured, delivered, prescribed, administered and reviewed to optimise the 
contribution that medicines make to producing informed and desired outcomes of 
patient care. 2 
Examples  of  medicines  management  services  already being  provided by primary 
care  organisations  were  identified  in  a  survey  carried  out  by  the  NPC (National 
Prescribing Centre) in 2001. The results of the survey, together with other work done 
in the area of medicines management, led to the classification of such services into 
five main types 3:
1. Systems  and  processes –  Inefficient  or  ineffective  medicines  management 
systems and processes can result in poor delivery of the service. Improving 
repeat prescribing, ensuring that guidance and policies are implemented are 
examples of services that are all part of medicines management. 
2. Health  of  the  public  –  Services  that  are  included  in  this  section  may  be 
developed for specific groups or for a disease area that is high on the local 
public  health  agenda. Risk management and disease prevention strategies 
are also ways in which medicines management services can help improve the 
health of the population. 
3. Medicines management at the interface – Systems and communication often 
break down at  the  interface between  health  care  settings,  leading to  poor 
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patient  care.  Medicines  management  and  better  communication  can  help 
prevent  this.  Examples  of  services  include  use  of  guidelines,  discharge 
planning, and use of patients’ own drugs in hospital. 
4. Patients  and their  medicines  –  Integration  of  health  and social  care  is  an 
important part of current NHS reforms. Medicines managament services could 
help bring together these aspects of  treatment,  allowing patients to remain 
safe  and  independent  in  their  normal  social  environment  for  as  long  as 
possible. Examples of such services include patient education, provision of 
support for carers, delivery of medication and repeat dispensing.
5. Clinical  medicines  management  –  involves  assessment  and  review  of 
prescribing  for  individuals.  This  type  of  service  includes  clinical  pharmacy 
interventions, and then also pharmaceutical care. 
All members of the clinical team need to work together to manage medicines 
effectively. Important members of this clinical team are the clinical pharmacists and 
their work in delivering pharmaceutical care.
1.1.1 Pharmaceutical care 
An important part of health services in the UK is clinical pharmacists working with 
pharmaceutical  care,  for  example  in  hospitals.  Over  the  past  few  years 
pharmaceutical care has emerged as a major topic in pharmacy. The concept of this 
was  developed  in  the  United  States  by  Douglas  Hepler  and  Linda  Strand. 
Pharmaceutical care is defined as “the responsible provision of drug therapy for the 
purpose of achieving definite outcomes that improve a patient’s quality of life.”4  
Pharmaceutical care involves the process through which a pharmacist cooperates 
with a patient and other professionals in designing, implementing, and monitoring a 
therapeutic plan that will  produce specific  outcomes for the patient.  This involves 
three major functions5: 
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1. Identifying potential and actual drug-related problems
2. Resolving actual drug-related problems
3. Preventing potential drug-related problems
Many lifesaving medicines work in small quantities; too much or too little can be the 
difference between successful  treatment,  unsuccessful  treatment,  or  toxicity.  It  is 
because of  the  recognised need to  help  patients  get  the most  benefit  from their 
medicines and to minimise the associated risks that the practice of pharmaceutical 
care became increasingly meaningful. 6
Pharmaceutical care reflects a systematic approach that makes sure that the patient 
gets the right medicines, in the right dose, at the right time and for the right reasons. 
Pharmacists can and do make a unique contribution to improving patient care. Of all 
the healthcare professions, pharmacists have the widest knowledge in the science 
and use of medicines. 6
Scotland has examples of  some of the best practice in pharmaceutical  care. The 
strategy  for  pharmaceutical  care  in  Scotland was  written  as  a  response  to  our 
national health: a plan for action, a plan for change. The main aim of this strategy is 
to work in partnership both with other healthcare professionals and with patients, to 
ensure they make the best and safest use of medicines. 6  Pharmacists have always 
worked to promote, maintain and improve health, but now this has been specifically 
identified as part of specialist public health practice. Scotland is leading the way in 
the development of this discipline and pharmacists are working in a more structured 
manner to integrate and develop systems to improve health.
 
1.2 Medication errors
Every day, about two and a half million medicines are prescribed in the community 
and in hospitals across the UK. Most of these medicines are used safely and they 
help people to get better or stay well. But sometimes errors occur and these can lead 
to  harm.  Some  of  the  errors  can  have  the  potential  to  cause  discomfort  or 
deterioration  in  the  patient’s  condition.  There  are  data  reports  from  the  NRLS 
(National Reporting and Learning System) of permanent harm and death where vital 
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medicines, such as medicines to treat epilepsy and to prevent strokes, had been 
omitted.7 Medication errors can cause unnecessary pain and harm to patients and 
can  even  lead  to  death.  In  addition,  medication  errors  account  for  a  substantial 
amount of NHS resources. 
A study of more than 18.000 patients admitted to two large hospitals over six months 
found that 6, 5 per cent of admissions related to harm from medicines. 
Medication errors are a part of what NPSA (National Patient Safety Agency) defines 
as a medication safety incident, and these kind of errors are incidents in which there 
has been an error in the process of prescribing, dispensing, preparing, administering, 
monitoring, or providing medicine advice, regardless of whether any harm occured. 7
A medication error is defined as “any preventable event that may cause or lead to 
inappropriate medication use or patient harm while the medication is in the control of 
health professional, patient or consumer.” 8
Errors can occur in all stages of the medication process. This process consists of 
these stages:
1. prescribing ( ordering a given medicine and dose)
2. dispensing (supplying medicines to individuals or to hospital wards)
3. preparation (preparing a dose of medicine for administration)
4. administration (administering the dose of medicine by the appropriate route 
and method)
5. monitoring (checking the administration and effect of a medicine)7
The  three  most  frequently  occurring  types  of  medication  errors  (omissions  and 
inaccuracies) are 7:
• Wrong dose, strength or frequency of medicine
• Omitted medicine 
• Wrong medicine
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1.2.1 Medication errors in hospital
Although most prescribing and dispensing happens in the community, over 80% of 
the medication incidents reported to the NRLS for a period, occurred in a hospital. 
The following section presents types of medication errors that can occur in hospital. 7 
Wrong dose or strength, or wrong frequency:
This is the most common type of medication error and accounts for 28, 2 per cent of 
all  the  reported  medication  incidents  in  hospitals.  This  error  may  be  overdoses 
resulting in toxicity, or underdoses, where the patient does not benefit from taking the 
medicine. 
Wrong route  : 
Wrong route errors occur when a medicine is prescribed or administered by a route 
other than that intented by the manufacturer of the product. These errors can also 
occur when a medicine is prescribed or administered by an inappropriate route for 
the patient, or by the correct route but to the wrong site.  
Omitted medicine:
This is the second most commonly reported type of medication incident in hospitals. 
Short term medication omissions are unlikely to cause harm to patients. For patients 
who rely on taking medicines regularly to stay well such as people with diabetes, 
epilepsy or transplants, missed doses may result in severe harm. For patients who 
are acutely unwell and require immediate treatment, the omission of a medicine, for 
example, intravenous antibiotics over a weekend, may cause harm.
Wrong medicine:
These errors  include  medicines  prescribed,  dispensed  or  administered,  that  the 
patient should not have had. This can occur as a result of confusion between two 
medicines  that  look-alike  or  sound-alike,  e.g  similar  medicines  names  or  similar 
packages for different medicines. 
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Another reason can be that it sometimes can be difficult for the doctors to find the 
patient’s drug history when admitted to  hospital.  Wrong sources used to  find the 
correct drug history, can lead to a wrong medicine prescribed. 
Mismatching between patient and medicine:
Incidents  which  are  reported  in  this  section  occur  in  all  stages  of  the  medicine 
process, and this type of error involves that a medicine is given to the ‘wrong patient’. 
It  is  an  important  issue  that  all  hospital  inpatients  should  wear  identification 
wristbands to help ensure that the right patient receives the right care. 
Wrong formulation:
Medicines are available in a variety of forms:
- Injections and infusions for intravenous administration
- Modified release tablets or liquid medicines for oral administration
Some 2.4 per cent of medication incidents from hospitals are reported with the right 
medicine given in the wrong form. An example of this could be that modified release 
is given instead of immediate release. 
1.2.2 Prescribing errors 
Prescription is the first stage of the medication process and errors here can lead to 
problems  further  in  the  process.  Errors  in  the  stage  of  prescribing  make 
approximately 16% of all medication errors, according to data from the NRLS.
The absolute frequency of prescribing errors leading to patient harm is not known. A 
reason  for  this  is  that  almost  all  studies  have  involved  detection  of  errors  by 
pharmacists which further will lead to avoidance of harm to patients. 
 
Prescribing errors occur for many reasons including inadequate knowledge of the 
patient  and their  clinical  condition,  inadequate knowledge of  the drug,  calculation 
errors, illegible handwriting, drug name confusion and poor history taking.8
Here are some examples of situations on how lack of knowledge and information 
about the patient can lead to prescribing errors:
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• Doctor/pharmacist is called to a ward to prescribe for a female patient without 
being aware that she is pregnant
• Prescribing a NSAID to a patient without knowing that the patient has a history 
of peptic ulcer disease. 
• Prescribing a drug that is excreted via kidneys without knowing that the patient 
has renal failure
• Prescribing a low-molecular-weight heparin for a patient without knowing the 
patient’s weight, this is needed to calculate the dose. 
• Prescribing a substance without  knowing that  the patient  is  allergic  to  this 
substance. 
Another reason for prescribing errors can be inadequate knowledge of the drug. The 
problem here can be drugs prescribed that are contraindicated of different reasons or 
combinations that may cause harmful drug interactions. An example can be if a beta-
blocker  is  prescribed  for  an  asthmatic  patient  without  realising  that  the  drug  is 
contraindicated in asthma. Another example can be if the cholesterol-lowering drug 
simvastatin is prescribed to a patient taking regular warfarin without knowing that in 
this case there is a risk of overanticoagulation. 
Calculation  errors  could  also  contribute  to  prescribing  errors.  For  some  potent 
medicines prescribed for adults and many medicines for children, the dose, volume 
or rate of administration needs to be calculated. These calculations can be complex 
and are therefore major sources of prescribing error. 8
Illegible prescriptions (handwritten) are also a major source of prescribing errors. In 
these  cases  the  person  who  is  reading  the  prescription  has  to  make  an  own 
interpretation, and if this interpretation is wrong this could lead to errors further in the 
medication process; in transcribing, dispensing or administration.  
Drug-name confusion (medicines with similar sounding names and drug names that 
look alike) may result in prescribing errors. This will be most common in the cases 
with handwritten prescriptions
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Another important reason for prescribing errors can be errors in the stage of taking 
drug history; an essential part of safe prescribing is an accurate medication history. 
1.2.3 Prescribing errors at hospital admission
In 2002, a study was done in the UK on prescribing errors in hospital inpatients, and 
incidence  and  clinical  significance  were  assessed.  Pharmacists  at  this  hospital 
prospectively  recorded  details  of  all  prescribing  errors  identified  in  non-obstetric 
inpatients during a 4 week period. Potential clinical significance was assessed by a 
pharmacist and a clinical pharmacologist.
A prescribing error was identified in 1, 5 % of the 36 200 medication orders that were 
written  during  the  study  period.  The  majority  of  all  errors  (61  %)  originated  in 
medication order writing, and most serious errors (58 %) originated in the prescribing 
decision. 9 
The process of prescribing medicines occurs during the whole stay in hospital, and 
an important part of this process is when medicines are prescribed at the time of 
admission. 
Up to  27  % of  all  prescribing errors in  hospitals  can be attributed to  incomplete 
histories  at  the  time  of  admission.10 Accurate  medication  histories  at  the  time  of 
hospital admission is an important element of medication safety and it is shown that 
accurate medication histories reduce errors and potential for harm 11. First, they may 
uncover  reasons  for  a  patient’s  illness,  such  as  adverse  drug  events  or 
nonadherence  to  drug  therapy.  Second,  medication  history  errors  may  result  in 
interrupted or inappropriate drug therapy during and following the hospital stay. Third, 
computerized physician order entry systems could fail  to detect  these errors.  For 
example  the  CPOE  systems  would  not  be  capable  of  detecting  unintentional 




Interventions made by pharmacist are an important part of improving the health care 
system worldwide. 
Classification of prescription interventions has generally been according to reasons 
for  the  intervention  for  example  prescribing  omission,  prescribing  error,  drug 
interaction and drug therapy monitoring problem.
An intervention is classified as 12:
- Review of medication
- Change of medication
- Change of formulation
- Modification of dose
- Continuation of medication
- Archive, monitor
- Add new drug
- Discontinue medication
1.3.1 Clinical significance of interventions
In  1992  a  study  was  published,  on  assessing  the  quality  of  ward  pharmacists’ 
interventions. In this study the interventions was measured using a six-point scoring 
system  that  have  been  employed  for  the  assessment  of  interventions  by  ward 
pharmacists 13. The different scores in the scoring system are listed below.  
1. Intervention detrimental to patient’s well-being
2. Intervention of no significance to patient care
3. Intervention  significant,  but  does not  lead to  improvement  in  patient 
care
4. Intervention significant and results in an improvement in the standard of 
care
5. Intervention  very  significant  and  prevents  a  major  organ  failure  or 
adverse reaction of similar importance
6. Intervention potenially life-saving
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The  study  was  over  a  12-month  period,  and  the  total  number  of  interventions 
recorded was 1315. The median of all the scores was 4, no potientially life-saving 
interventions or any which were detrimental to patients’ care were recorded.
Some 53 per cent of all the interventions were scored as 4 or above, and therefore 
lead to an improvement in patient care. With these results, the study concluded that 
pharmacists do have a role in improving the quality of patient care.
Another study has been done on pharmacists contributions made on acute medical 
wards at a hospital in London. The objectives in this study were to document the 
number,  types  and  clinical  significance  of  interventions  made  by  the  admission 
pharmacists. In the study a total of 122 patients were seen and 194 interventions 
made,  this  make  an  average  of  1.6  interventions  per  patient  in  total.  All  of  the 
interventions made by the pharmacists were considered to be of either moderate or 
major  significance.  The  most  common intervention  made  after  a  pharmacist  had 
taken  a  drug  history  was  recommending  starting  medicines  which  had  been 
unintentionally omitted. 14
In both studies mentioned above, the conclusion says that pharmacists contributions 
at hospitals are important. Pharmacists can reduce potential harm to patients and 
reduce errors, through their work e.g. on admission wards. 
1.4 The ‘Safer Patients Initiative’
Around 16 million people are admitted to hospital each year in the UK. The majority 
are treated safely and successfully. However, a disturbingly high number will find that 
something goes wrong with their treatment or care, resulting in unnecessary harm, 
pain and suffering, sometimes leading to death. 15
It is estimated that over 850 000 incidents harm or nearly harm NHS’ hospital in the 
UK each year.  Incidents include medication errors,  infections during treatment on 
intensive care units, and infections associated with surgery. 16
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To reduce medication errors and events, there is a project called “The Safer Patients 
Initiative”, that is a joint venture between The Health Foundation and the Institute for 
Healthcare Improvement.  The vision of the Safer Patient Initiative is that no patient 
should suffer unnecessary harm, pain or suffering as a result of error or planned 
medical intervention (UK- safer patient initiative overview).  The over-all goal of the 
Safer Patients Initiative is a 50 per cent reduction in adverse events across each of 
the hospitals taking part. 17 
In  2006 there were  20 hospitals  in  UK that  joined the Scheme. In  Scotland it  is 
Dumfries and Galloway Royal Infirmary (NHS Dumfries and Galloway) working with 
The Ayr Hospital (NHS Ayrshire & Arran.)
1.5 Medicines reconciliation
As a part of the safer patient initiative, Ayr Hospital has just started a form developed 
to  capture  medicines  reconciliation.  Medication  reconciliation  is  a  technique  for 
identifying discrepancies in drug regimen and the aim of medicines reconciliation on 
hospital admissions is to ensure that medicines prescribed on admission correspond 
to those that the patient was taking before admission .18, 19 When medicines have not 
been reconciled, problems can occur, for example patients might receive the wrong 
dose of their medicine, may not receive their medicine at all or the stay in hospital 
might be extended.20
The National Prescribing Centre defines medicines reconciliation as 18:
- Collecting  information  on  medication  history  using  the  most  recent  and 
accurate sources of information to create a full and current list of medicines. 
- Checking  or  verifying  this  list  against  the  current  prescription  chart  in  the 
hospital  ensuring  any  discrepancies  are  accounted  for  and  actioned 
appropriatly. 
- Communicating through appropriate documentation, any changes, omissions 
and discrepancies. 
Medicines reconciliation can occur when patients are admitted to hospital, transferred 
to other units within the hospital or to another hospital, or discharged from hospital. 
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Medicines  reconciliation  should  take  place  as  soon  as  possible  after  admission, 
usually within 24 hours. 18
Factors that may contribute to medicines reconciliation errors include the following:
- No access to the patients prescription list from primary care
- Discrepancies between the primary care presription list and the medications 
the patient is taking. This mat happen because the patient is no longer taking 
prescribed  medications,  because  they  are  taking  medications  they  have 
obtained  themselves  (for  example,  over-the-counter  medicines,  herbal 
medicines or vitamins), or because they are taking the incorrect dose.
- Difficulties in obtaining an accurate account of a patient’s medication, which 
may be caused by an acute condition, sensory or cognitive impairment, lack of 
access to family or carer support, or language barriers.18
Among complicated patients, complete agreement between the medication list and 
what the patient is actually taking occurs in only 5 % of patients 21. A reason could be 
that many prescribed drugs are a part of treatment that has originally been initiated 
by general practitioners (GPs), and it can therefore be a challenge to find the correct 
medication history when the patient is admitted to hospital. There are many different 
sources that  a  doctor  and a  pharmacist  can use to  get  as  much information  as 
possible about the drug history to the patient, and some examples are:
• Patient (with interview at admission)
• Relative / Carer
• Patient’s Own Drugs
• GP Referral Letter
• GP Practice
• Emergency Summary Care
• Nursing Home Chart
• Previous Discharge Letter
• Community Pharmacy
Consulting the patient is one of the most important ways to find out what medicines 
the patient is currently taking, when admitted to hospital. 
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Important (core) components of a complete medication history  22  : 
1. Pharmacists  should  introduce  themselves  to  the  patient  and  explain  the 
purpose of the visit / consultation. 
2. Identify any drug allergies or serious adverse drug reactions, ensuring that the 
nature of the reaction is obtained. 
3. Ascertain any information the patient or carer is able to provide about their 
drug therapy from (in order of priority): 
a. Their own knowledge
b. Their own medication 
c. A GP referral letter
d. A copy of recent prescription list
e. Community pharmacist
f. A recent discharge notification
g. Telephoning or faxing information from the GP
h. Medical notes
4. Ensure that following are recorded:




e. Lenght of therapy if appropriate
f. Any recently discontinued medicines and the reason for stopping
5. Ensure that items such as inhalers, eye drops, topical preparations, injections 
and courses of medication held in readiness are included as patients may not 
consider these as medicines. 
6. Ascertain their adherence to the prescribed medication regimen.
7. Identify an self-treatment e.g OTC, herbal, homeopathic remedies.
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8. Include any important drug related information such as
a. Dialysis fluids
b. Maintenance doses for steroids
c. Home nebulisers
d. Dosettes filled community pharmacies (blisterpacks)
e. Source of supply, if unusual
9. Where practical,  drug histories should be obtained from a minimum of two 
sources. 
1.5.1 Medication reconciliation; current practice at Ayr Hospital
The medicines reconciliation form used in Ayr Hospital is for the doctor to use when a 
patient is seen for the first time at hospital, and the form has now been embedded in 
the  acute  medicines  admissions  clerk  in  proforma.  In  this  form  the  doctor  can 
document the source of information, admission medicines and also information about 
adverse  reactions and allergies.  After  this,  the pharmacist  has the opportunity  to 
make changes, to try to make a complete drug history and also add other important 
information. The form should be completed within 24 hours after admission, by doctor 
first, and then by the pharmacist. This process has so far been very much pharmacist 
driven and a challenge is to engage the medical staff. As a part of evaluating this 
service an audit is carried out every month detailing out of 20 patients how many 
have medicines reconciliation completed. 
The  medicines  reconciliation  form  used  in  Ayr  hospital  consists  of  the  following 
sections (see appendix I for a view of the form): 
- Source of information 
- Admission medicines
- Action  changes made by pharmacist
1. Suspending
2. Amending
3. Stopping a medicine
4. Changes in dose, strength, frequency
- Information about OTC / Herbal / Homeopathic / Illicit substances
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- Further information (other information that could be important and relevant for 
the patient’s stay in hospital.)
- Adverse reactions / Allergies
- Questions to be answered by the doctor
1. Are you satisfied this medication history is complete and accurate?
2. If NO, what further action is necessary?
1.5.2 Pharmacist-led interventions in medicines reconciliation
Pharmacists can make interventions in different stages; at admission is one of them, 
and this is often connected to medicines reconciliation. 
In a systematic review there was searched (in 11 databases) for studies published in 
english in or after 1950 until june 2007 that addressed any intervention designed to 
improve  medicines  reconciliation  and  prevent  medication  error  at  the  point  of 
admission into hospital. Twelve studies were included in the review, and 8 of these 
included involvement of a clinical pharmacist. 23
Involvement  of  pharmacists in  medicines  reconciliation  were  examined  in  one 
randomised controlled trial (RCT), two before and after trials and five observational 
studies presented in the systematic review. The RCT was carried out in the USA, and 
the other studies took place in the UK. 24, 25, 26, 27, 28, 29, 30, 31
The RCT reported that  the number of  discrepancies between hospital  and home 
medication  fell  after  pharmacist  involvement  compared  with  standard  care.  The 
numbers of discrepancies fell from 44 per 100 patients to 19 per 100 patients. 24
In both before and after studies, the intervention of the pharmacist allowed a greater 
number of medication errors to be identified and corrected than in the control arm of 
the study. 
The five last of the eight studies, were prospective studies based in the UK. They 
compared  a  pharmacist’s  obtained  medication  history  with  that  obtained  by  the 
25
admitting physician. In three of these studies the numbers of error per patient was 
202 per 100 patients and 136.4 per 100 patients. 27, 28, 29
The two last studies showed some interesting results. In one of them pharmacists 
appeared to omit more medicines than physicians, but in the other study findings 
were equal to the other studies; there was found a higher error rate in physicians 
than pharmacists. 30, 31   
1.6 Clinical setting
The study was carried out on an acute medical receiving ward at the Ayr Hospital. 
Patients that are admitted to this ward either have a referral from GP, or they come 
via the A & E. This ward has 18 beds, divided in four single rooms, two four-bedded 
rooms and one six-bedded room. In this ward there usually is a ward round twice 
daily,  and the ward  round team consists  of  a  pharmacist,  a  staff  nurse  and two 
doctors. The clinical pharmacy service at station 7 is provided by two pharmacists at 
the morning and one pharmacist at the afternoon. 
An important part of this pharmacists’ job is medicines reconciliation at the time when 
the patients  are admitted to  the ward.  The pharmacists  use approximately 15-20 
minutes on each patient. They try to see as many patients as possible, to find their 
correct drug history and check that every patient have all their medicines prescribed 
with the right dose and frequency. To have all this information as correct as possible 
different information sources are used, and at least two sources should be used. As a 
part of the ward round team, they give advice and recommendations to the doctors 
about what should be prescribed, but they are also allowed to transcribe medicines 
and do corrections by themselves. 
Most of  the patients that  are admitted to  station 7,  are moved to other wards or 
discharged quite fast after they have been seen by the doctors. This involves that 
some of the patients will not receive pharmaceutical care in this ward. 
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2. Aims, objectives, subjects and settings
2.1 Aims
(1) To characterise the nature and quantify the incidence of medicines omissions and 
inaccuracies  in  patients  during  the  process  of  admission  to  hospital;  and  (2)  To 
evaluate the medicines reconciliation service (MR service)
2.2 Objectives
• Review the literature on MR services and on clinical evaluation of pharmacists’ 
contributions.
• Define the new MR service at Ayr Hospital
• Design  and  apply  a  template  to  summarise  anonymously  each  patient’s 
clinical  condition  and  medical  history  on  admission.  Collect  data  on  the 
changes made by the pharmacist to the physician’s drug history. 
• Evaluate the clinical  significance of the changes made at  individual  patient 
level using an expert group of three clinical pharmacists 
• Report the findings in terms of frequency and type of drug history corrections 
and the assessed impact of the contribution of the service to patient care. 
Receive feedback from pharmacists and clinicians at Ayr  hospital  by group 
interview
2.3 Subjects and settings
Data  on  the  changes made by the  pharmacist,  at  station  7,  Ayr  Hospital  will  be 
collected.  The MR service will  be audited using prospective follow up of  patients 
recruited into the service (during weekdays, n=200) and retrospective audit of those 




The  project  was  designed  as  a  prospective  audit  survey  of  patients’  records  at 
admission to compare the drugs first prescribed by the doctor, with the list that the 
pharmacist  makes.  In  addition,  the  researcher  also  evaluated  the  use  of  the 
medicines reconciliation service for the included patients. The study period was set to 
be 2-4 weeks depending on number of patients included during the period. 
3.1 Ethical approval
An application for ethical approval of the survey was sent to the Ayrshire and Arran 
Health Board Ethics Committee. Together with the application, there was sent a short 
project protocol, a consent form and a patient information sheet. 
The  project  was  approved  the  14th of  January  2009.  (Consent  form and  patient 
information sheet; see appendix II and III)
3.2 Literature review
The literature was obtained from research in electronic library databases including 
Medline (PubMed). The databases were searched to find literature on both clinical 
significance of interventions, and literature on medicines reconciliation. 
Some literature was also obtained from accessing relevant NHS documents locally 
and via the internet. 
In PubMed there were searched in MeSH, and also in free text. Both were necessary 
to ensure that all relevant information were included. 
3.3 Observation of current practice at Ayr Hospital
The researcher was introduced to the current practice at Ayr Hospital by following a 
pharmacist in different wards, included the acute medical receiving ward, and the aim 
of this was mainly to observe how pharmaceutical care is delivered by pharmacists. 
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In  addition,  there  was  also  observed  how the  medicines  reconciliation  service  is 
delivered in station 7. 
3.4 The study
3.4.1 Pilot phase
The researcher  designed a template  for  data  collection,  and tested  the  template 
during a pilot phase of approximately two weeks. The testing was done on a number 
of 20 cases in total, that amount to 10 % of 200. Necessary changes and corrections 
were done during the pilot phase, and the final template was also tested to ensure 
that all the important information could be recorded in the template. 
The  final  template  (see  a  view  in  appendix  IV)  contained  anonymised  patient 
information (age and gender), a summary of the patient’s clinical condition, including 
past medical history and present complaint, a list of drugs prescribed at admission 
and types of medication errors. 
The types of medication errors were divided in the following categories: 





The recording template also contained a page to evaluate the MR-service, and this 
part consisted of the following sections:
- Information sources used by pharmacist (if the section was answered or not, 
and types of sources used)
- Information sources used by physician/doctor (if the section was answered or 
not, and types of sources used)
- Did the doctor complete the allergy-section? (Options: ‘Yes’ or ‘No’)
- Was the doctor satisfied with the medication history? (Options: ‘Yes’, ‘No’ or 
‘Not answered’)
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- Numbers  of  changes/corrections  made  by  the  pharmacist  to  the  list  of 
admission medicines. The following changes were recorded:
o Drugs added to the list




3.4.2 Inclusion of patients
The initial  aim was to include 200 patients admitted in weekdays and 50 patients 
admitted in weekends. 
Since the researcher was not a part of the health care team for these patients, there 
was necessary to ask every patient for consent. Before any information about the 
patient records could be used, each patient had to agree to take part in the study by 
signing a patient consent form. 
The inclusion criteria was that the patient had to be admitted to station 7 during the 
study period, and the patient had to be suitable for the study and also be able to give 
consent. 
The pharmacists and the researcher handed out information sheets to every patient 
who was assessed to be suitable and able to give consent. The information sheet 
contained information about the purpose of the study, and what it would involve for 
them to take part. Then they had time to read the information, and time to decide if 
they wanted to be included in the study or not. The patients, who wanted to be a part 
of the study, could then ask questions to the researcher, if they had any, and then 
they signed the consent form. The patient received a copy of this consent form, the 
researcher had one copy, and the original was filed in the patient’s medical notes. A 
list of patient numbers, names and birth dates for all the included patients was made 
during the inclusion period, and this list was kept separate from the data template to 
keep this information anonymous.   
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3.4.2.1 Inclusion of patients in weekends
Information about how many patients admitted to the ward  in the weekends was 
obtained from a ward notebook.  In this  book the nursing staff  record all  patients 
admitted to station 7, presenting complaints and time for when they are transferred to 
other wards, or discharged. This made it possible for the researcher to follow up the 
patients that were admitted to the ward during the weekend. 
An inclusion criteria for these patients was that they had to be seen by a pharmacist 
after the weekend. 
3.4.3 Data collection
After  a  patient  was  included to  the study and the consent  form was  signed,  the 
patient’s  clinical  file  was  read  and  necessary  information  was  collated  into  the 
anonymised  template.  All  the  changes  and  corrections  for  each  patient  were 
observed and recorded, by using the MR service form. During the pilot phase, the 
researcher discovered that admission medicines written on this form were not always 
equal to what was actually prescribed. Access to the electronic prescribing system 
was therefore needed. 
At  the  morning  of  each  day  of  data  collection,  there  were  printed  out  a  list  of 
everything that was prescribed for all the patients that at that time where admitted at 
station 7, before the patients were seen by the pharmacist. This was written in the 
template  as  ‘current  drugs prescribed at  admission’.  It  was then possible  for  the 
researcher to record types of medication errors that the doctors had done, in terms of 
interventions.  (The  frequency  and  type  of  drug  history  corrections  made  by 
pharmacist)
3.5 Expert group
The expert group consisted of 4 clinical pharmacists from Ayr Hospital. The expert 
assigned  a  category  of  clinical  impact  to  each  intervention  according  to  an 
established set of definitions for clinical significance (see introduction). 
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3.5.1 Scoring system
The pharmacists in the expert group found the wording in the scoring system unclear, 
and  it  was  therefore  a  need  to  make  an  interpretation  of  the  criteria.  To  set  a 
standard  for  the  assessment,  the  expert  group  decided  to  assume  that  the 
interventions  made  by  pharmacist  would  not  have  been  done  by  any  other 
professionals during the hospital stay. 
Interpretation of the criteria for assessment of interventions 
1. Intervention detrimental to patient’s well-being
• An  intervention  which  appears  to  be  inappropriate  based  on  the 
available information (presenting complaint, past medical history) e.g. 
getting a medicine prescribed which would be contraindicated based on 
the available information. This also include if the patient came in on a 
drug that needs to be reviewed. 
2. Intervention of no significance to patient care
• Clarification  of  any  ambiguity  in  prescribing  documentation  which  is 
unlikely to cause harm to the patient e.g. specifying route for eye drops 
(unlikely to be many instances of this with HEPMA system). This criteria 
also include time changes which are not significant. 
3. Intervention significant, but does not lead to improvement of patient care
• A change to the prescription which has no impact on the therapeutic 
benefit for the patient e.g. switches to formulary preparation (Gaviscon 
D3 forte to Adcal D3, Gaviscon to Peptac). Intervention is deemed as if 
it had not been made the patient may not have received this medicine 
while in hospital. This also includes interventions with drugs that were 
assessed  by  the  expert  group  to  be  less  significant  for  the  patient 
because of less clinical effectiveness. 
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4. Intervention significant and results in an improvement in the standard of care
• If  the  intervention  had  not  been  made  there  may  have  been  a 
detrimental effect on the long-term standard of care or elements of the 
existing  treatment  plan  may  have  been  lost  or  compromised  e.g. 
continuation  of  medicines  the  patient  was  taking  prior  to  admission 
which remain appropriate in view of available information. 
5. Intervention very significant  and prevents  a major  organ failure or  adverse 
reaction of similar importance
• An intervention with the potential to prevent clinical harm of a non-life-
threatening nature. It is not possible to assess if the intervention would 
have prevented a major organ failure but its potential to do so can be 
assessed.  E.g.  suspending  aspirin  in  suspected  CVA,  getting  a 
medicine discontinued if the patient has a suspected allergy (excluding 
anaphylaxis)
6. Intervention potentially life-saving
• Intervention which prevents administration of a toxic dose or a medicine 
for  which  there  is  a  clear  and  life-threatening  contraindication  e.g. 
warfarin  prescribed  in  presence  of  GI  bleed,  lithium  prescribed  for 
patient  with  lithium  toxicity,  medication  which  has  been  taken  in 
overdose  prescribed  for  the  patient.  This  will  be  based  on  clinical 
assessment  of  the  risk  based  on  the  medicine  involved,  presenting 
complaint and past medical history. 
3.5.2 Assessment of clinical significance
After the interpretation of the criteria was done, the expert group got a information 
sheet for each patient. The sheet contained information about the patient’s age and 
gender, presenting complaint,  drugs prescribed at admission, past medical history 
and types of errors made by doctor/changes made by pharmacist; all the information 
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that  were  assessed  by  the  researcher  to  be  relevant.  Then  all  the 
interventions/contributions  were  assessed  with  clinical  significance  together  with 
information about the patient. In some cases more information was needed as basis, 
and  then  the  expert  group  used  the  electronic  prescribing  system  to  get  this 
information. They discussed every case together and agreed one clinical significance 
for each case. The expert pharmacists managed to assess all the interventions within 
three meetings on one hour each. 
3.6 Group interview and feedback
According to the objectives the results should have been presented to clinicians and 
pharmacists  at  Ayr  Hospital.  After  the expert  group meetings were finished there 
were not enough time to gather clinicians and pharmacists to have a group interview 
as planned. Researcher had some feedback from some of the clinical pharmacists 




4.1 Inclusion of patients
The initial aim of the study was to include 200 patients admitted in weekdays and 50 
patients admitted in weekends, during the study period of 2-4 weeks. The researcher 
experienced  that  it  was  difficult  to  achieve  this  number,  and  after  5  weeks  the 
researcher had managed to include 106 patients to the study. Because of lack of 
more time the data collection had to stop after these 5 weeks. 
The reason it was so difficult to include patients was the need to have consent from 
every patient. Many of the patients were not suitable to be included in the study, and 
during the study period the researcher only managed to include less than 50 per cent 
of all the patients that were admitted during the period. Examples of reasons for a 
patient to be assessed as not suitable/not able to give consent:
- Clinical condition (patient in with confusion, overdose etc, or very unwell at the 
time of admission
- Disease (e.g. dementia)
 
Some patients were assessed as not suitable for the study, because they did not 
have the new medicines reconciliation form in their notes. There were also a few 
patients that did not want to be a part of the study after they had read the information 
sheet.  Most  of  these patients  did  not  give  a  reason  why  they  didn't  want  to  be 
included. 
The following table shows distribution of age and gender in all consenting patients. 
Table 1: Distribution of age and gender in all consenting patients (n=106)
Male Female
Number (%) 49 (46.2) 57 (53.8)
Mean (SD)  age 63.8 (15.7) 64.1 (16.7)
Median (IQR) 
age
66 (49,75) 68 (54,76)
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Table 2 shows the most common presenting complaints for the patients included. 
Some of the patients were admitted with more than one presenting complaint,  so 
these patients may count for more than one of the presenting complaints in the table. 
Table 2: Most common presenting complaints (n=106)
It was also difficult to include patients that had been admitted in the weekends. Most 
of these patients had left the hospital during the weekend and the rest of the patients 
had  been  moved  to  other  wards.  The  researcher  followed  up  these  patients  by 
visiting other wards, but this turned out to be very time demanding. In addition some 
of the patients had not been seen by a pharmacist yet and were often discharged 
before a pharmacist managed to see the patients. Of the total 106 included patients 
only 12 were patients admitted in the weekends. 
4.2 Pharmacist contributions
All the changes and corrections made by pharmacist to the physician’s drug history, 
were recorded. In the study period there were recorded 255 contributions, and this 
was recorded for 105 patients. Researcher did not get access to the medical notes to 
one consenting patient, this was because of discharge. The MR-form for this patient 
was evaluated, so the researcher has chosen to keep the patient as included in the 
study. 
The median number of discrepancies found per patient was 2,4 and no discrepancies 
were found in 25/105 (23.8 %) of the cases. The highest number of discrepancies 
found for one patient was 10. The following table shows a classification of type of 
errors made by physician/doctor.
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Patients (%)
SOB 33 ( 31.1)
CP 32 ( 30.2)
Pain 14 ( 13.2)
Cough 9 ( 8.5)
Diarrhoea 9 ( 8.5)
Vomiting 9 ( 8.5)
Arm/facial 
weakness 6 ( 5.7)
Anaemia 5 ( 4.7)
Collapse 4 ( 3.8)
Swollen leg w/pain 4 ( 3.8)
Table 3:  Frequency Distribution of Pharmacist Contributions
Type of Medication Error Count ( %)
Wrong dose/strength 23 (9.0 %)
Wrong frequency 17 (6.7 %)
Omitted medicine 147 (57.6 %)
Wrong medicine 23 (9, 0 %)
Wrong formulation 12 (4.7 % )
Other changes 33 (13.0 %)
Total 255 (100 %)
Other changes included the following:
- Administration times changed. Following drugs were involved: Lisinopril, 
allopurinol, amlodipine, doxazosin, loratadine, alendronic acid, gabapentin, 
insulin (three cases) and quinine sulphate
- One drug switched to another drug
o Calcichew changed to adcal D3 (two cases)
o Omeprazole changed to esomeprazole
o Bumetanide changed to furosemide
o Co-dydramol changed to co-codamol
o Tramadol changed to co-codamol
o Naproxen changed to etodolac
o Gaviscon changed to peptac (two cases)
o Diltiazem changed to adizem XL preparation
- Stat doses prescribed (eight cases)
- Latanoprost eyedrops changed from drops in one eye to both eyes
- Dose changes without changes in daily dose
o Dexamethasone 4 mg once daily changed to 2 mg twice daily (daily 
dose still 4 mg)
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o Furosemide 120 mg od changed to 80 mg am and 40 mg noon (daily 
dose still 120 mg)
- Creon capsules; ‘as required’ dose added to regular dose because dose 
varies depending on intake
Table 4: Frequency of types of contributions and distribution per patient. 


















































There were many different drugs involved in the pharmacist’s contributions and the 
255 changes and corrections were distributed on a total of 119 drugs. Table 5 shows 
the most common medicines involved. (See appendix VI for a table with all the 
involved drugs distributed in the different categories of errors.)










4.3 Expert group – assessment of clinical significance of contributions
The expert group made an assessment of clinical significance of all the interventions 
made by pharmacist, to see how important these contributions are. Some 67.5 per 
cent of all the interventions were assessed to be a clinical significance of 4 – 
interventions significant and results in an improvement in the standard of care. No 
potentially lifesaving interventions were recorded, and only one intervention was 
assessed to be detrimental to patient’s well-being. 
Table 6: The clinical significance of the pharmacist contributions
Assessed clinical significance Count % 
1 Intervention detrimental to patient’s wellbeing  1 0.4
2 Intervention of no significance to patient care 26 10.2
3 Intervention significant, but does not lead to improvement of 
patient care 39 15.3
4 Intervention significant and results in an improvement in the 
standard of care 172 67.5
5 Intervention very significant and prevents a major organ failure 
or reaction of similar importance 17 6.7
6 Intervention potentially life-saving 0 0
TOTAL 255 100
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Distribution of clinical significance


















Figure 1: Distribution of scores in all the interventions made by pharmacist. 
The intervention assessed as detrimental to the patient’s wellbeing 
In  this  case  the  patient  was  taking  oxycodone  5  mg  daily  at  home,  and  when 
admitted to hospital 10 mg daily was prescribed. The pharmacist changed this to the 
dose that the patient was taking at home, but the patient was admitted with pain and 
should have stayed on the prescribed dose for review. 
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The interventions assessed as very significant
As listed in the table above, there were 17 cases assessed with a clinical significance 
of 5 – interventions that are very significant and prevent a major organ failure or 
adverse reaction of similar importance. The following section is a description of these 
cases. 
In  three  cases a  PPI  was  omitted,  and in  all  three  cases this  was  important 
medicines due to presenting complaint. 
• Omeprazole was omitted and the patient was admitted with anaemia
• Lansoprazole was omitted and the patient was admitted with epigastric pain
• Esomeprazole was omitted and the patient was admitted with anaemia
In six cases important cardiovascular medicines were omitted. These cases were 
distributed on  two  patients,  both  of  them admitted  with  chest  pain.  Medicines 
involved were bisoprolol, aspirin, isosorbide mononitrate (two cases), ramipril and 
clopidogrel. 
Four of the cases involved a medicine prescribed, that the patient should not be 
taking. 
• Alendronic acid was prescribed but the patient was not using this medicine at 
home. The patient was admitted with oesophagitis. 
• Simvastatin was prescribed although the patient already was on atorvastatin. 
• Aspirin  was  prescribed  when  the  patient  was  admitted  with  a  suspected 
cerebrovascular accident
• Paracetamol  was  prescribed  although  the  patient  was  allergic  to  this 
substance.  
In three cases wrong frequency or/and dose were prescribed. 
• Folic acid was prescribed daily, but patient was usually on a weekly dose. In 
addition the patient was on a weekly dose of methotrexate. 
• Capecitabine  was  prescribed  with  both  wrong  dose  and  wrong  frequency. 
These errors made a big difference from the dose the patient should have 
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had. The doctor prescribed 500 mg once daily,  but the patient was usually 
taking 2000 mg twice daily. 
In one case naproxen was prescribed when patient was admitted with symptoms 
that could indicate stroke. Naproxen was in this case changed to etodolac (which 
the patient was usually on) and then suspended by pharmacist. 
Examples  of  cases  assessed  as  not  significant  for  the  patient  were  when 
administration times were changed or stat-doses prescribed. 
The type of error with the highest frequency was omitted medicines. The table below 
shows the distribution of clinical significance of the interventions made by pharmacist 
in the errors that were classified as omitted medicines. The interventions/errors are 
divided in terapeutic cathegories according to the BNF-system. 
Table 7: Clinical significance of interventions made in the category omitted medicines. 




Gastro-intestinal system - - 7 8 2 - 17 (11.6%)
Cardiovascular system - - - 36 6 - 42 (28.5%)
Respiratory system - - 1 29 - - 30 (20.4%)
Central nervous system - - 3 25 - - 28 (19.1%)
Infections - - - 2 - - 2 (1.4%)
Endocrine system - 1 - 8 - - 9 (6.1%)
Obstetric, gynaecology and 
urinary tract disorders - - - 3 - - 3 (2.0%)
Malignant disease and 
Immunosuppression - - - - - - 0 (0.0%)
Nutrition and blood - - - 3 - - 3 (2.0%)
Musculoskeletal and joint 
diseases
- - - 3 - - 3 (2.0%)
Eye - - 1 - - - 1 (0.7%)
Ear, nose and oropharynx - - 1 1 - - 2 (1.4%)
Skin - - 1 3 - - 4 (2.7%)
Immunological products and 
vaccines
- - - - - - 0 (0.0%)
Anaesthesia - - - - - - 0 (0.0%)

















4.4 Evaluation of the MR-service
Researcher managed to evaluate this service in 105 patients. The last patient was 
discharged before researcher had access to the patient’s medical notes. During the 
data collection the researcher recorded how the MR-service was delivered by doctors 
and  pharmacists.  This  included  if  the  doctor  completed  all  the  sections,  which 
changes and corrections the pharmacist had to make and what information that was 
added by pharmacist. 
It was recorded how many drugs that should have been on the admission medicines 
list  and  changes/corrections  done  by  pharmacist  on  this  list.  The  changes  and 
corrections was classified in the following sections: 
- Drugs added to the list (not written by doctor)
- Drugs removed from the list (wrong medicines written by doctor)
- Doses changed (included doses both  changed from what  was  written  and 
doses added to a drug already on the list)
- Frequencies  changed  (included  frequencies  both  changed  from  what  was 
written and frequencies added to a drug already on the list)
- Other changes/corrections
The two most common contributions in other changes were addition of administration 
times and writing of brand-names. 
The list of admission medicines should contain all medicines that the patient were 
taking at home, before admitted to hospital. Of the 774 drugs that should have been 
written on the MR-form, 297 (38.4%) drugs had to be added by pharmacist. 
In the remaining 477 drugs written by doctor there was a high frequency of errors. In 
128 cases there was a need for corrections in dose; 28 (%) doses were changed by 
pharmacist  and 100 (%) doses were  added.  In  147 cases there was a need for 
corrections in frequencies; 9 (%) frequencies were changed and 138 (%) frequencies 
were added. There were also 20 cases of other changes and corrections. 
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The following table shows how all these changes and corrections were distributed on 
all the patients with evaluated forms.
















































Total number of drugs 







In  addition  the  doctors  had  written  29  medicines  wrong,  and  these  drugs  were 
removed from the list during the MR-process. (See appendix VII to see distribution all 
types of changes/corrections per patient) 
In the MR-form, the doctors and pharmacist are supposed to document what sources 
they have used to find the correct drug history for the patient. Only in 20 (19 %) of the 
cases the doctor had documented this information, and in the other 85 (81 %) cases 
the  section  was  not  answered.  The  pharmacists  had  documented  information 
sources in 104 (99%) of all the cases. 
The most common information sources used were patient, patient’s own drugs, GP 
referral letter, contact with GP practice and use of previous discharge letter. 
The next section to be evaluated was the ‘adverse reaction and allergies’-section. In 
76 ( 72.4%) of the cases the section was answered, in 16 ( 15.2 %) cases the 
pharmacist had to answer the section and in 13 ( 12.4 %) cases the doctor had just 
partly answered and then the section was completed by pharmacist. 
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The last section to be completed by the doctors was the following questions ‘Is the 
doctor satisfied the medication history is complete and accurate?’ and ‘If NO, what 
action is necessary?’ In 99 (94, 2 %) cases the questions were not answered. 
In total there was only one case where the doctor had completed the form correctly 
and no changes or corrections were needed. In this particular case all sections was 
completed and all questions answered. In total there were six cases where the doctor 
had not documented anything on the form, and in 13 cases only the allergy-section 
was completed. 
The result was also compared to the actual errors made in the prescribing process, 
by  comparing  changes  in  the  form  with  changes  made  to  the  doctors  list  of 
prescribed medicines. The comparison was just done visually (with comparing tables 
in  appendix 5  and 7),  and the aim of  this  was  to  see if  there was  any possible 
connection between these results. 
In the cases where the doctor had completed the MR form almost correctly,  few 
prescribing errors were made and also few changes or corrections by pharmacist 
were  necessary.  In  the  cases were  the forms were  only  partly  completed  or  not 
completed at all, a higher number of errors were recorded. 
4.5 Feedback from clinical pharmacists at Ayr Hospital
Some of the key comments that the researcher received from the clinical pharmacists 
at Ayr Hospital are listed below:
- The results give detailed information as to exactly what has had to be added 
by the pharmacist to ensure the form is completed.
- The  results  are  useful  evidence  and  can  be  used  as  basis  to  future 
discussions with senior medical staff. This can help to engage all medical staff 




5.1 Limitations in the study
5.1.1 Inclusion of patients and data collection
In the inclusion of patients the researcher experienced that it was difficult to include 
patients, because many of them were unwell, not able to give consent or not suitable 
for  other  reasons.  Since these patients  were  missed because they  could  not  be 
included in the study, the numbers in the study may not be accurate to describe the 
current situation at the acute medical ward at Ayr Hospital. If it had been possible to 
include  all  the  patients  that  were  admitted  to  the  ward  in  the  study  period,  the 
numbers of medication errors and interventions would have been more accurate, and 
this number would have described the actual conditions in a more accurate way. 
The researcher had to do this study prospectively, and all the patients included had 
to be seen by a pharmacist before data collection was possible. This involved the 
constraint that the researcher only could include patients when the pharmacist was 
working (usually between 8.30 am and 4.30 pm), and therefore a lot of patients could 
be admitted and then discharged without having the chance to be included. Patients 
missed by the pharmacist because of discharge, for example, were also missed by 
the researcher and could not be included. 
Although the initial aim of the study was to include 250 patients in total, a number of 
106  patients  was  included  and  could  be  representative  to  describe  the  current 
situation. The included patients showed an equal distribution of gender and this is 
another statement to indicate that the numbers are representative. 
5.1.2 The expert group
The method used by the expert group could have been done in another way. The 
pharmacists discussed the interventions together and a result of this can be that they 
may  have  affected  each  other.  The  results  could  have  been  different  if  all  the 
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pharmacists had assessed the interventions independently and then met to have the 
discussion.
5.2 Contributions  made  by  pharmacist  and  assessment  of  clinical  
significance
In  the  study period  of  5  weeks  there  were  identified  255 contributions  made  by 
pharmacist,  distributed on 105 patients.  This made a rate of 2.4 per patient.  The 
frequency of interventions made per patient needs to be compared to other studies 
found in the literature review (see introduction). In one study there were recorded 
1315 interventions over a 12-month period, which gives an average of 110 in one 
month. There is no information on how many patients that the interventions were 
identified.  In  another  study  122  patients  were  included  in  the  study  and  194 
interventions were made. This makes an average of 1.6 interventions per patient in 
total. That study was over a 7-days period. 
The numbers found in this study seem to be higher than the other studies, when 
looking  at  the  results.  This  indicates  that  the  frequency  of  contributions  made 
according to prescribing errors, is quite high at this ward. Still  it is limitations with 
comparing this study with the two earlier studies, because there is some information 
missing (number of patients), and also because there are some differences on length 
of study period and on study design. 
A lot of patients could not be included in the study because of the need for consent. 
Many of these patients that could not give consent had a lot of medicines prescribed. 
Interventions  made  in  medication  errors,  could  probably  have  higher  clinical 
significance for patients that are taking more medications and have more complex 
diseases.  If  the  researcher  had  managed  to  include  these  types  of  patients  in 
addition to the other patients, the results of the assessment on clinical significance 
could have been different. 
In the assessment of clinical significance there was assumed that the interventions 
would not have been done if the pharmacist hadn’t been there. This was necessary 
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as a standard before the expert group could assess all the interventions equally. In 
some cases it would not be accurate to assess the intervention with this standard, 
because the medication errors could be discovered during the hospital stay. Many 
patients know very well what kind of medicines they are taking, and in these cases 
the patients might have asked for medicines not given, corrected the dose or even 
refused to take medicines that were wrong medicines prescribed. Then it would have 
been possible to discover the prescribing errors and avoid or reduce harm. 
In addition the patient would have been followed up during the hospital stay, and for 
example  omissions  of  important  medicines  could  have  been  discovered  through 
monitoring. One example of this could be; if medicines for high blood pressure were 
missed at  admission,  the patient  could have experienced symptoms of increased 
blood pressure. Due to this, medicines needed would probably have been prescribed 
by the doctors. If antidiabetics are omitted it could be possible to discover this via 
monitoring of blood glucose, both in hospital and when the patient is at home.
Even though the errors are discovered, the examples mentioned above show that the 
errors often are discovered as a result of an adverse effect,  and the errors have 
already caused harm for the patient.    
An example of a potentially serious case can be that the prescribing errors are not 
discovered during the hospital stay. These errors may lead to errors on the discharge 
letter,  and this could further cause the patient to not have a necessary supply of 
important medicines. In some cases the medicines that are omitted at the hospital, 
may not be prescribed by the GP because the medicines are missed of the discharge 
letter. An example of this could be if a medicine to prevent stroke is omitted; this 
could in long term lead to serious harm for the patient
Though,  there  is  a  possibility  that  the  GP may contact  the  hospital,  if  there  are 
questions concerning medicines that suddenly have been discontinued. 
Since this study has involved detection of errors by pharmacists, it is difficult to say 
how harmful these errors would have been for each individual patient. Detection of 
errors with following changes and corrections, may result in avoidance of harm to 
patients, and it is only possible to say if the error was potentially harmful. 
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The assessment of clinical significance shows that the impact of the contribution of 
the service has high importance. The high frequency of medication errors at the time 
of admission reflects that there is a need for pharmacists working with medicines 
reconciliation.  Approximately  74  % of  all  contributions  were  assessed  to  have  a 
clinical importance of 4 or above, and these results show that pharmacists make an 
important  contribution  to  the  patients  with  reducing errors  and potential  harm for 
patients.  
One reason for the high frequency of prescribing errors could be that the doctors are 
very busy and the errors are a result of lack of time. There can often be difficult and 
time demanding to use many different sources to find a correct drug history for the 
patient, and the acute ward at Ayr hospital is very busy most of the time. 
Another  important  issue  to  consider  is  that  in  this  project  the  doctors/physicians 
where  unaware  that  they  were  participating  a  study  while  the  pharmacists  were 
aware. This could have affected the results, because there is a possibility that the 
pharmacists have made a even better job when they were aware of being a part of a 
study. 
In addition, the doctors know that the pharmacist  is there to check their medication 
list,  and this  might  be a reason that  they do not  do things more correctly.  If  the 
researcher had managed to include more patients from the weekend, it would have 
been possible to see if there were any significant differences between when doctors 
work in weekends without a pharmacist, and when they work along with pharmacists 
in the weekdays. 
The  high  frequency  of  interventions  in  some  of  the  terapeutic  classes  could  be 
explained by  the  presenting  complaints  and  past  medical  history  to  the  included 
patients.  As  shown  in  the  results  there  were  cardiovascular  medicines  and 
asthma/COPD medicines that were most involved in the interventions, which may 
have a connection with the most commonly presenting complaints; CP and SOB. 
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5.3 Patients admitted in the weekends 
As mentioned in both methods and results there was difficult to include patients that 
had been admitted in the weekends. Only 10 patients were included and this were 
not enough cases to tell if there is any difference between patients admitted in the 
weekends and patients admitted in the weekdays. The difference in those patients 
will be that those admitted in weekends will not always be recruited in this service, 
and the aim was to see if this made a difference for patients admitted in weekends. 
Although, it may be possible to say something about patients in the weekends, based 
on the results from the study. As listed in table 4 in results there are two means with 
their confidence intervals that are interesting; omitted medicine (mean 1.40 with CI: 
1.02, 1.78) and total contributions (imean 2.43 with CI: 1.96, 2.90). This means that 
the possibility  is  that  19 out  of  20 patients  will  at  least have one omission when 
admitted  to  hospital  and  two  contributions  in  total.  Since  patients  admitted  in 
weekends will not receive the medicine reconciliation service from pharmacist before 
Monday, there is a possibility that important medicines are omitted for several days. 
This could lead to harm for the patients, and may potentially be more harmful than 
omissions discovered by pharmacist  short  time after  admission. Although there is 
possible to indicate that there are differences, more numbers will be needed before it 
is possible to conclude with differences. 
   
5.4 Evaluation of medicines reconciliation service
The results of the evaluation were mainly that the doctors completed the form in very 
few  of  the  observed  cases. The  medicines  reconciliation  service  with  using  the 
admission medicines form is quite new at Ayr Hospital and this might be a reason for 
the  observed  results.  Another  explanation  of  this  can  be  that  the  process  of 
determining the patient’s drug history can be quite time demanding and also difficult.
The acute ward is often very busy and it is possible that in many cases the doctor 
don’t have time to complete the forms. Still, the results indicate that there is a need 
for improvement on how this service is delivered by doctors.   
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When results of this evaluation was compared with results from the changes made to 
the prescribed medicines, there was possible to see that often errors made on the 
MR form also were made in the prescription process. 
5.5 Feedback from clinical pharmacists on the evaluation of the MR-service
Some of  the key comments were  that  the results  give detailed information as to 
exactly what had to be added by the pharmacist to ensure the form is completed 
fully. The results were assessed to be useful evidence of this and could be used as 
basis for future discussions the pharmacists have with senior medical staff to help to 
engage all medical staff in the process. 
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6. Conclusion
The project has shown that it is possible to characterise the nature and quantify the 
incidence of omissions and inaccuracies in patients during the process of admission 
to  hospital,  by  doing  a  prospective  study.  To  find  a  more  correct  frequency  of 
prescribing errors made at hospital admission, it is necessary to include all types of 
patients. This was not possible in this study because of the need for consent from the 
patients before they could be included in the study. 
To identify the importance of patients that are excluded from the MR service because 
of admission in the weekends, there is necessary to include more patients. Then it 
can be possible to compare these patients with patients admitted in weekdays. 
The clinical significance of all the pharmacist’s contributions could be assessed with 
the use of a scoring system. A major part of the contributions were assessed to be 
either significant or very significant and could potentially result in an improvement in 
the standard of care. 
 
The project has shown that pharmacists have an important role in the process of 
medicines reconciliation. Their work with finding a correct drug history when patients 
are admitted at hospital can reduce and even avoid potential harm for the patients. 
The project has also shown that it is a need for improvement in how the medicines 




7.1 Appendix I: Medicines reconciliation form used at Ayr Hospital 
           
  
  
Adverse Reactions/Allergies       None Known                 or 
Are you satisfied this medication history is complete and accurate?    Yes          No  
If No what further action is necessary (Contact GP etc) ……………………………………… Tick when resolved   
Pharmacist review signature………………………………Date/Time …………….Beep No ……
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Patient Emergency Care Summary
Relative/Carer Nursing Home Chart
Patient’s Own Drugs Previous Discharge Letter
GP Referral Letter Repeat Prescription slip
GP Practice Other (Please state)
Admission Medicines Action    Note: Unless otherwise  indicated below, medicine should be  continued on
prescription sheet
Name, Form, Route (specify if not oral) Dose Frequency
eg 3X





OTC/ Herbal/ homeopathic/ illicit substances            Further information eg compliance aid, recent discontinued medicines
Medicine/Substance Reaction
Multidisciplinary Medicines Reconciliation Form
Must be started by admitting Clinician within 24 hours
Source of Information (Use at least two sources) (Tick)















Name of Researcher:  Anita Reinaas Lysheim 
 
                Please initial box 
 
1. I confirm that I have read and understand the information sheet dated 
 12/12/2008 for the above study. I have had the opportunity  
  to consider the information, ask questions and have had these answered 
 satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw  
 at any time, without giving any reason, without any medical care or legal  
 rights being affected. 
 
3. I understand that relevant sections of any of my medical notes and data  
 collected during the study, may be looked at by responsible individuals  
 from Ayr Hospital pharmacy department. I give permission for these 
    individuals to have access to my records.  
 
 





________________________ ________________ ___________________ 




_________________________ ________________ ___________________ 
Name of Person taking consent Date  Signature 




_________________________ ________________ ___________________ 
Researcher   Date  Signature 
 
 
When completed,  1 for patient;  1 for researcher site file;  1 (original) to be kept in medical notes. 
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7.3 Appendix III: The information sheet
PATIENT INFORMATION SHEET
The study of Recording of Medicines on Admission to Hospital 
You are being  invited  to  take  part  in  a  research study.   Before  you  decide it  is 
important  for  you to  understand why the research is being done and what  it  will 
involve.  Please take time to read the following information carefully. Talk to others 
about the study if you wish. 
Ask us if there is anything that is not clear or if you would like more information. 
Take time to decide whether or not you wish to take part.
What is the purpose of the study?
On admission to hospital a list of the medicines you are taking at home are recorded 
by the doctor and this is checked by the pharmacist. We have started to use a new 
form to do this.
The aim of this study is to find out if this form helps us do this by comparing the list 
the doctor has taken to the list the pharmacist takes.
One final year pharmacy university student from Norway who is currently working 
with the pharmacists in Ayr Hospital and Strathclyde University will carry out the 
study. The student’s name is Anita Reinaas Lysheim.
Why have I been chosen?
You have been chosen because you have been admitted to our medical receiving 
ward in Ayr Hospital (station 7) during the study time period.
It is hoped we will study a total of about 200 patients during the time period.
Do I have to take part?
No.  It is up to you to decide whether or not to take part.  If you do, you will be given 
this information sheet to keep and be asked to sign a consent form. You are still free 
to withdraw at any time and without giving a reason.  
A decision to withdraw at any time, or a decision not to take part, will not affect the 
standard of care you receive. 
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What will happen to me if I take part?
If you decide to take part in this study, your notes will be accessed when you in 
hospital.  
The information contained in your notes about the list of medicines you were taking 
before you came into hospital will be used by the student in the research. 
Any information taken from your notes will be kept anonymous. 
What do I have to do?
You are only required to give permission for the information in your notes to be used 
as part of the study.
You will not have to do anything, complete any forms or visit any clinics or hospitals 
during the study. 
If you decide to take part in the study, you will be asked to sign a consent form. This 
will allow us to access your notes when you are in hospital and use the information in 
your notes. 
After this you will not be asked to do anything else.
What are the possible benefits of taking part?
There are no direct benefits to your treatment by taking part in the study. 
However, if the study produces good results it will give us information on how to 
change the recording form to help us collect information in the future. 
This may benefit patients in Ayrshire and Arran in the future.
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What if there is a problem?
Any complaint about the way you have been dealt with during the study will be 
addressed. 









If you remain unhappy and wish to complain formally, you can do this through the 
NHS Complaints Procedure. Details can be obtained from Ayr Hospital.
Will my taking part in the study be kept confidential? 
Yes.  All the information about your participation in this study will be kept confidential. 
You will be given a copy of the information sheet and a signed consent form to 
keep.
Thank you for taking time to read the information sheet and for considering taking 
part in this study. 
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7.4 Appendix  4 – Final data collection template
STATION 7 – the study of Recording of Medicines on Admission to 
Hospital








• Wrong dose, strength or frequency of medicine






Current drugs prescribed (at admission):
Name of medicine, form, 
route
Dose Frequency Other relevant notes
63
Audit of the MR – service: 
Information sources used by:
The Doctor The Pharmacist
Patient   .










Did the doctor complete the “adverse reactions/allergies” – section?
                               
Is the doctor satisfied this medication history is complete and accurate?
                               
Number of:
o Drugs added to the list: ____
o Drugs removed from the list: ____
o Doses changed: ____
o Frequencies changed: ____
o Other changes/corrections: __
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Yes No
Yes No Not answ.











7.5 Appendix V. Detailed table of distribution of errors per patient
Patient 
nr














1 1 1 0 0 0 0 0
2 1 1 0 0 0 0 0
3 1 1 0 0 0 0 0
4 3 0 0 2 0 1 0
5 4 0 0 1 1 2 0
6 2 1 1 0 0 0 0
7 7 0 0 7 0 0 0
8 2 1 0 0 0 0 1
9 5 0 0 1 0 0 4
10 2 0 0 1 0 0 1
11 2 0 1 1 0 0 0
12 1 1 0 0 0 0 0
13 3 1 0 2 0 0 0
14 1 0 0 0 1 0 0
15 5 0 0 4 0 0 1
16 0 0 0 0 0 0 0
17 1 0 0 1 0 0 0
18 0 0 0 0 0 0 0
19 9 0 0 9 0 0 0
20 2 0 0 2 0 0 0
21 6 0 1 4 1 0 0
22 4 1 1 1 0 1 0
23 2 1 0 0 0 0 1
24 2 0 0 2 0 0 0
25 3 1 1 0 0 0 1
26 3 0 0 3 0 0 0
27 1 0 1 0 0 0 0
28 0 0 0 0 0 0 0
29 2 0 0 0 2 0 0


















31 2 0 0 1 1 0 0
32 0 0 0 0 0 0 0
33 6 1 1 0 1 1 2
34 3 0 0 2 0 0 1
36 0 0 0 0 0 0 0
37 1 0 0 1 0 0 0
38 2 0 0 1 1 0 0
39 0 0 0 0 0 0 0
40 1 0 0 1 0 0 0
41 0 0 0 0 0 0 0
42 1 0 0 1 0 0 0
43 1 0 0 1 0 0 0
44 4 1 1 0 1 0 1
45 6 1 0 5 0 0 0
46 3 0 0 2 0 1 0
47 2 0 0 1 0 0 1
48 2 0 0 2 0 0 0
49 0 0 0 0 0 0 0
50 3 0 1 0 0 0 2
51 3 0 0 1 0 2 0
52 2 0 0 1 1 0 0
53 0 0 0 0 0 0 0
54 2 0 0 1 1 0 0
55 3 0 0 3 0 0 0
56 6 0 0 4 1 0 1
57 9 0 1 7 1 0 0
58 3 0 0 1 1 0 1
59 0 0 0 0 0 0 0
60 4 0 0 2 1 1 0


















62 0 0 0 0 0 0 0
63 1 0 0 0 0 1 0
64 1 0 0 1 0 0 0
65 2 0 0 2 0 0 0
66 10 1 0 4 1 1 3
67 4 0 0 4 0 0 0
68 2 0 0 2 0 0 0
69 0 0 0 0 0 0 0
70 2 0 0 0 1 0 1
71 3 0 0 3 0 0 0
72 4 0 0 3 1 0 0
73 5 2 0 2 0 0 1
74 1 0 0 1 0 0 0
75 0 0 0 0 0 0 0
76 0 0 0 0 0 0 0
77 4 0 0 4 0 0 0
78 1 0 0 0 1 0 0
79 3 0 1 2 0 0 0
80 0 0 0 0 0 0 0
81 9 3 3 2 0 0 1
82 3 0 1 1 1 0 0
83 2 0 0 2 0 0 0
84 0 0 0 0 0 0 0
85 8 0 0 8 0 0 0
86 8 0 0 8 0 0 0
87 0 0 0 0 0 0 0
88 0 0 0 0 0 0 0
89 2 0 0 1 1 0 0
90 8 0 0 1 0 0 7


















92 1 0 0 1 0 0 0
93 0 0 0 0 0 0 0
94 3 0 0 2 0 0 1
95 0 0 0 0 0 0 0
96 0 0 0 0 0 0 0
97 1 0 0 0 0 1 0
98 2 0 0 2 0 0 0
99 0 0 0 0 0 0 0
100 1 0 0 0 1 0 0
101 0 0 0 0 0 0 0
102 2 1 1 0 0 0 0
103 5 2 1 2 0 0 0
104 0 0 0 0 0 0 0
105 3 0 0 3 0 0 0
106 2 0 0 1 0 0 1
TOTAL 255 23 17 147 23 12 33
Patient nr 35 is exluded from the table (see results for explanation)
68















Adcal D3   1 3   4
Alendronate   2 1  1 4
Allopurinol   1   1 2
Amiodarone   1    1
Amitriptyline   1    1
Amlodipine   2   1 3
Aspirin 1  5 1 1  8
Atenolol   2    2
Beclomethasone 1   1   2
Bendroflumethiazide   1    1
Betahistine   1    1
Bezofibrate   1    1
Bisacodyl   2    2
Bisoprolol   3    3
Brinzolamide 1      1
Bumetanide    1  1 2
Calcichew D3      2 2
Capacitabine 1 1     2
Carbocisteine   1    1
Chlorphenamin   1    1
Cinnarizine 1      1
Citalopram   3    3
Clopidogrel   1    1
Clotrimazole   1    1
Co-amilofruse   1    1
Co-codamol 1  2    3
Co-dydramol   1   1 2
Creon      1 1
Dexamethasone      1 1
Diclofenac   1    1
Digoxin   1    1
Dihydrocodeine   1    1
Diltiazem      1 1
Diprobase   1    1
Dipyridamol   1    1
Domperidone   1    1
Doxazosin      1 1
Doxycycline   1    1
Enalapril   1    1
Esomeprazole   2    2
Estradiol   1    1
Etodolac    1 1
Ezetimibe   1    1
Finasteride   1    1
















Fluticasone   2    2
Folic acid  1     1
Furosemide 2 1 2   1 6
Fybogel   1    1
Gabapentin    1  1 2
Gaviscon      2 2
Glicliazide  1     1
Glyceryl trinitrate   10    10
Half securon   1    1
Hyoscine butylbrom   2    2
Hypromellose   1    1
Insulin  1 1   3 5
Isosorbide mononitr.  1 2    3
Lactulose 1   5   6
Lansoprazole   1    1
Latanoprost      1 1
Levomepromazine   1    1
Levothyroxine 1 1 1    3
Lisinopril      1 1
Loperamide   1    1
Loprazolam   1    1
Loratadine      1 1
Losartan   1    1
Mebeverine    2   2
Meptazinol   1    1
Metformin 3      3
Methotrexate 1      1
Mirtazipine   1    1
Mometasone furoate 1      1
Montelukast   1    1
Movicol  1     1
Naproxen   1    1
Nasonex   1    1
Nefopam   1    1
Nicorandil    1   1
Omeprazole 1 2 5   1 9
Orlistat   2    2
Oxybutinin   2    2
Oxycodone 1      1
Oxycontin 1      1
Paracetamol  2 3 1   6
Paroxetine   2    2
Peptac   2    2
Persantin Retard   1    1
Pizotifen 1      1
















Premarin   1    1
Premique   1    1
Propranolol  1   1  2
Promethazine 1      1
Pulmicort   1    1
Quinine sulphate 1  3   1 5
Ramipril   2    2
Ranitidine    1   1
Risendronate   1    1
Salbutamol   14  4  18
Salmeterol   1    1
Senna  1 1 2   4
Seretide 2 1 4 1 4  12
Simvastatin   2 1   3
Slow K   1    1
Sodium chloride   1    1
STAT doses      8 8
Symbicort   1    1
Synalar ointment   1    1
Tamsulosin   1    1
Temazepam  1     1
Terbinafine   1    1
Terbutaline   1    1
Tiotropium   2 1   3
Tramadol  1 1   1 3
Trazadone   2    2
Uniphyllin   1    1
Venlafaxine   1  1  2
Xalatan   1    1
TOTAL 23 17 147 23 12 33 255
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7.7 Appendix VII.  Recording of changes in the MR form

















1 0 0 1 0 0 4
2 0 1 0 0 0 2
3 0 0 1 0 1 3
4 2 0 4 0 0 6
5 0 2 3 1 1 7
6 1 0 1 9 0 9
7 8 0 1 1 0 9
8 2 1 0 1 0 9
9 0 0 0 0 1 14
10 1 0 1 1 1 10
11 1 0 1 1 0 6
12 0 0 2 4 0 10
13 2 0 1 0 1 5
14 11 0 0 0 0 11
15 6 1 1 3 0 9
17 0 0 4 5 0 5
18 0 0 0 0 0 0
19 1 0 2 7 1 8
20 7 0 1 3 0 10
21 4 4 3 2 0 18
22 7 0 0 0 0 7
23 2 1 1 0 0 12
24 1 0 2 1 0 3
25 15 0 0 0 0 15
26 0 2 1 0 0 8
27 0 0 0 0 1 6
28 0 0 0 0 0 8
72

















29 0 2 1 1 0 8
30 10 0 0 0 0 10
31 4 0 0 0 0 4
32 6 0 0 0 0 6
33 2 1 3 0 0 18
34 1 0 1 1 0 10
35 0 0 3 2 0 5
36 1 0 0 2 0 3
37 0 0 1 0 0 7
38 0 1 2 2 0 21
39 9 0 0 0 0 9
40 2 0 0 0 0 2
41 3 0 0 0 0 4
42 1 0 1 0 0 8
43 0 0 1 1 0 1
44 12 0 0 0 0 12
45 5 0 0 0 0 10
46 2 0 1 0 0 4
47 2 0 0 0 0 10
48 3 0 6 6 0 9
49 1 0 0 0 0 1
50 1 1 0 1 0 14
51 1 0 0 0 3 4
52 3 0 6 8 0 11
53 11 0 0 0 0 11
54 12 0 0 0 0 12
55 3 1 5 7 0 11
56 18 0 0 0 0 18
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57 7 0 4 3 0 11
58 17 0 0 0 0 17
59 0 0 2 3 0 3
60 1 1 3 7 0 10
61 1 3 6 6 0 10
62 0 1 0 0 0 1
63 0 0 2 4 0 4
64 0 0 1 2 0 4
65 1 0 0 0 0 2
66 15 0 0 0 0 16
67 2 0 2 2 0 4
68 5 0 0 0 0 5
69 0 0 0 0 1 1
70 0 2 3 2 0 8
71 1 0 2 2 0 3
72 12 0 0 0 0 12
73 1 0 5 3 0 6
74 0 0 1 1 0 1
75 0 0 0 0 1 4
76 2 0 0 0 0 2
77 9 0 0 0 0 9
78 3 0 0 0 0 3
79 5 1 2 4 0 15
80 1 0 1 2 0 3
81 5 0 5 5 0 10
82 0 1 0 0 0 11
83 7 0 0 0 0 7
84 0 0 1 1 0 2
74

















85 6 0 3 3 0 9
86 3 0 2 3 0 9
87 0 0 1 0 0 3
88 0 0 0 0 3 3
89 1 0 2 6 0 7
90 0 0 0 5 0 11
91 0 0 0 0 0 0
92 1 0 2 1 0 9
93 1 0 0 0 0 2
94 1 0 1 0 1 12
95 0 0 0 0 1 10
96 0 0 3 2 2 5
97 0 0 1 1 0 5
98 2 0 1 0 0 11
99 0 0 0 0 0 0
100 0 1 0 0 0 7
101 0 1 2 2 0 4
102 0 0 2 1 0 5
103 2 0 4 2 0 12
104 0 0 0 0 0 0
105 0 0 1 3 1 7
106 1 0 1 1 0 2
Total 297 29 128 147 20 774
Patient nr 16 is excluded from the table (see results)
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